Speech and behavioral contaminations as non-epileptic automatic behavior in Parkinson’s disease

Close metadata

Recommended articles:

Criteria of syndrome frailty in Parkinson´s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(3):52-56

Tremor-dominant form of Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(4):28-35

Nocturia in Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(4):48-54

Results of a pilot study of the structure and evaluation of the therapy for chronic sleep disorders in comorbid patients with chronic cerebral ischemia. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(4):118-126

Associations of serum neuromarkers with clinical features of Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(4):145-152

Problems in organizing neurosurgical care for patients with Parkinson’s disease in the Russian Federation. Burdenko's Journal of Neurosurgery. 2024;(3):5-13

The association of single-nucleotide polymorphism rs6265 of the brain-derived neurotrophic factor gene with clinical features in Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(7):82-88

Sarcopenia as a non-motor symptom of Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(9):15-22

Association of inflammation and chronic fatigue syndrome in patients with Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(9):79-87

Electric activity of the brain at early and late clinical stages of experimental modeling of Parkinson’s disease, an impact of hemantane. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(9):129-134

Parkinson’s disease is characterized by a variety of motor and non-motor symptoms. More than two hundred years have passed since its description, but we still discover its new manifestations. Abnormal behaviors include impulse control disorders, dopamine dysregulation syndrome, psychotic disorders and others. However, two new phenomena have been recently described in patients with PD. It can manifest in the form of doing inappropriate actions which patient doesn’t recognize, or pronouncing/writing unsuitable words and phrases. Patients can’t remember such episodes, but find «signs» of their unconscious activity or hear about it from attestors. This article represents a review of literature on unrelated communication interlude and automatic behavior in Parkinson’s disease and discusses its possible reasons.

Keywords:

Parkinson’s disease

abnormal behaviors

behavioral disorders

unrelated communication interlude

automatic behavior

sleep and wakefulness disorders

excessive daytime sleepiness

hypersomnia

sleep attacks

narcoleptic syndrome

narcolepsy

orexin

orexinergic system

Authors:

Yakovleva O.V.

Razumovsky Saratov State Medical University

Levin O.S.

Russian Medical Academy of Continuous Professional Education

SPIN RSCI: 5342-1373
Scopus AuthorID: 57147160800
ORCID: 0000-0003-3872-5923

Received:

09.09.2021

Accepted:

14.09.2021

List of references:

Barone P, Antonini A, Colosimo C. et al. PRIAMO study group. The PRIAMO study: a multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson’s disease. Mov Disord. 2009;24(11):1641-1649. https://doi.org/10.1002/mds.22643
Parkinson J. An essay on the shaking palsy. J Neuropsychiatry Clin Neurosci. 2002;14(2):223-236.
Fernandez HH, Friedman JH. Punding on L-dopa. Mov Disord. 1999;14(5):836-838. https://doi.org/10.1002/1531-8257(199909)14:5<836::aid-mds1018>3.0.co;2-0 "> 3.0.co;2-0" target="_blank">https://doi.org/10.1002/1531-8257(199909)14:5<836::aid-mds1018>3.0.co;2-0
Guilleminault C, Billiard M, Montplaisir J, Dement WC. Altered states of consciousness in disorders of daytime sleepiness. Journal of the Neurological Sciences. 1975;26(3):377-393. https://doi.org/10.1016/0022-510x(75)90209-9
Fusegi K, Yoritaka A, Hattori N, Mori H. Automatic behavior in Parkinson’s disease. Parkinsonism Relat Disord. 2015;21(1):84-85. https://doi.org/10.1016/j.parkreldis.2014.11.004
Fusegi K, Hattori N, Mizuno Y, Mori H. The unrelated communication interlude (UCI) — an automatic behavior phenomenon in Parkinson’s disease. Parkinsonism Relat Disord. 2012;18(8):986-989. https://doi.org/10.1016/j.parkreldis.2012.05.006
Walker RH. Automatic behavior and communication due to pramipexole. J Clin Mov Disord. 2016;11:3-9. https://doi.org/10.1186/s40734-016-0038-7
Weintraub D, Koester J, Potenza M. et al. Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients. Arch Neurol. 2010;67(5):589-595. https://doi.org/10.1001/archneurol.2010.65
Erga AH, Alves G, Larsen J. et al. Impulsive and Compulsive Behaviors in Parkinson’s Disease: The Norwegian ParkWest Study. J Parkinsons Dis. 2017;7(1):183-191. https://doi.org/10.3233/JPD-160977
Gatto EM, Aldinio V. Impulse Control Disorders in Parkinson’s Disease. A Brief and Comprehensive Review. Front Neurol. 2019;10:351. https://doi.org/10.3389/fneur.2019.00351
Ghorayeb I, Loundou A, Auquier P, Dauvilliers Y, Bioulac B, Tison F. A nationwide survey of excessive daytime sleepiness in Parkinson’s disease in France. Mov Disord. 2007;22(11):1567-1572.
Valko PO, Waldvogel D, Weller M, Bassetti CL, Held U, Baumann CR. Fatigue and excessive daytime sleepiness in idiopathic Parkinson’s disease differently correlate with motor symptoms, depression and dopaminergic treatment. Eur J Neurol. 2010;17(12):1428-1436. https://doi.org/10.1111/j.1468-1331.2010.03063.x
Brodsky MA, Godbold J, Roth T, Olanow CW. Sleepiness in Parkinson’s disease: a controlled study. Mov Disord. 2003;18(6):668-672.
Iakovleva OV, Poluektov MG, Lyashenko EA, Levin OS. Subjective and objective subtypes of excessive daytime sleepiness in Parkinson’s disease. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 2019;119(9):44-50. (In Russ.). https://doi.org/10.17116/jnevro201911909244
Somnology and sleep medicine: national guideline in memory of A.M. Vein and Y.I. Levin. Poluektov M.G., eds. M.: Medforum; 2016. (In Russ.).
Babkina OV, Poluektov MG, Levin OS. The heterogeneity of daytime sleepiness in Parkinson’s disease. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 2016;111:(6-2):60-70. (In Russ.). https://doi.org/10.17116/jnevro20161166260-70
Yakovleva OV, Lyashenko EA, Poluektov MG. Dysfunction of the orexin system in Parkinson’s disease. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 2018;118(6):82-89. (In Russ.). https://doi.org/10.17116/jnevro201811806282
Fronczek R, Overeem S, Lee SY, et al. Hypocretin (orexin) loss in Parkinson’s disease. Brain. 2007;130:1577-1585. https://doi.org/10.1093/brain/awm090
Thannickal TC, Lai YY, Siegel JM. Hypocretin (orexin) cell loss in Parkinson’s disease. Brain. 2007;130(Pt 6):1586-1595. https://doi.org/10.1093/brain/awm097
Ulivelli M, Rossi S, Lombardi C, et al. Polysomnographic characterization of pergolide-induced sleep attacks in idiopathic PD. Neurology. 2002;58(3):462-465. https://doi.org/10.1212/wnl.58.3.462
Bliwise DL, Trotti LM, Juncos J, et al. Daytime REM sleep in Parkinson’s disease. Parkinsonism Relat Disord. 2013;19(1):101-103. https://doi.org/10.1016/j.parkreldis.2012.08.003
D’Ambrosio S, Castelnovo A, Guglielmi O, et al. Sleepiness as a Local Phenomenon. Front Neurosci. 2019;13:1086. https://doi.org/10.3389/fnins.2019.01086
Krueger JM, Nguyen JT, Dykstra-Aiello CJ, Taishi P. Local sleep. Sleep Med Rev. 2019;43:14-21. https://doi.org/10.1016/j.smrv.2018.10.001
Vyazovskiy VV, Olcese U, Cirelli C, Tononi G. Prolonged wakefulness alters neuronal responsiveness to local electrical stimulation of the neocortex in awake rats. J Sleep Res. 2013;22(3):239-250. https://doi.org/10.1111/jsr.12009
Bernardi G, Siclari F, Yu X, et al. Neural and behavioral correlates of extended training during sleep deprivation in humans: evidence for local, task-specific effects. J Neurosci. 2015;35(11):4487-500. https://doi.org/10.1523/JNEUROSCI.4567-14.2015
Fattinger S, Kurth S, Ringli M, et al. Theta waves in children’s waking electroencephalogram resemble local aspects of sleep during wakefulness. Sci Rep. 2017;7:11187. https://doi.org/10.1038/s41598-017-11577-3
Gorgoni M, Ferlazzo F, Ferrara M, et al. Topographic electroencephalogram changes associated with psychomotor vigilance task performance after sleep deprivation. Sleep Med. 2014;15:1132-1139. https://doi.org/10.1016/j.sleep.2014.04.022
Blaivas AJ, Patel R, Hom D, Antigua K, Ashtyani H. Quantifying microsleep to help assess subjective sleepiness. Sleep Med. 2007;8(2):156-159. https://doi.org/10.1016/j.sleep.2006.06.011
Boyle LN, Tippin J, Paul A, Rizzo M. Driver Performance in the Moments Surrounding a Microsleep. Transp Res Part F Traffic Psychol Behav. 2008;11(2):126-136. https://doi.org/10.1016/j.trf.2007.08.001
Silkis IG. Generation of ponto-geniculo-occipital (pgo) waves as a possible cause of impairments to visual perception during microsleep. Neurosci Behav Physiol. 2013;43:122-128. https://doi.org/10.1007/s11055-012-9701-0
Hertig-Godeschalk A, Skorucak J, Malafeev A, et al. Microsleep episodes in the borderland between wakefulness and sleep. Sleep. 2020;43(1):23-29. https://doi.org/10.1093/sleep/zsz163
Poryazova R, Benninger D, Waldvogel D, Bassetti CL. Excessive daytime sleepiness in Parkinson’s disease: characteristics and determinants. Eur Neurol. 2010;63(3):129-135. https://doi.org/10.1159/000276402
Möller JC, Unger M, Stiasny-Kolster K, et al. Continuous sleep EEG monitoring in PD patients with and without sleep attacks. Parkinsonism Relat Disord. 2009;15(3):238-241. https://doi.org/10.1016/j.parkreldis.2008.05.009
Pizza F, Filardi M, Moresco M, et al. Excessive daytime sleepiness in narcolepsy and central nervous system hypersomnias. Sleep and Breathing. 2019;23:1-10. https://doi.org/10.1007/s11325-019-01867-7
Avorn J, Schneeweiss S, Sudarsky L, et al. Sudden uncontrollable somnolence and medication use in Parkinson disease. Arch Neurol. 2005;62:1242-1248. https://doi.org/10.1001/archneur.62.8.1242
Paus S, Brecht HM, Koster J, et al. Sleep attacks, daytime sleepiness, and dopamine agonists in Parkinson’s disease. Mov Disord. 2003;18:659-667. https://doi.org/10.1002/mds.10417
Michinaga S, Hisatsune A, Isohama Y, Katsuki H. An anti-Parkinson drug ropinirole depletes orexin from rat hypothalamic slice culture. Neuroscience Research. 2010;68(4):315-321. https://doi.org/10.1016/j.neures.2010.08.005
Fialová M, Dvořák P, Dušek P, et al. Narcolepsy with cataplexy and Parkinson’s disease. Case Report. Neuro Endocrinol Lett. 2015;36(3):226-230.
Naeimi S, Montplaisir J, Gagnon JF, Postuma R. Neurodegeneration in narcolepsy‐associated REM sleep behavior disorder. Movement Disorders Clinical Practice. 202l;7:208-210. https://doi.org/10.1002/mdc3.12895
Nikitina MA, Mukhin KY, Glukhova LY, et al. Clinical lateralizing signs in symptomatic temporal lobe epilepsy. Epilepsy and paroxysmal conditions. 2015;7(2):59-64. (In Russ.).
Odinak MM, Svistov DV, Prokudin MYu, et al. Clinical symptomatology of seizures in temporal epilepsy. Epilepsy and paroxysmal conditions. 2012;4(2):34-39. (In Russ.).

Close metadata